Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ReposiTrak (TRAK) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for ReposiTrak (TRAK) over the last 16 years, with Q3 2025 value amounting to $2.7 million.

  • ReposiTrak's Other Operating Expenses rose 138.04% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 615.09%. This contributed to the annual value of $12262.0 for FY2025, which is N/A changed from last year.
  • ReposiTrak's Other Operating Expenses amounted to $2.7 million in Q3 2025, which was up 138.04% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, ReposiTrak's Other Operating Expenses ranged from a high of $4.0 million in Q1 2021 and a low of $1.8 million during Q2 2021
  • Moreover, its 5-year median value for Other Operating Expenses was $2.5 million (2024), whereas its average is $2.5 million.
  • Data for ReposiTrak's Other Operating Expenses shows a peak YoY increase of 2587.82% (in 2021) and a maximum YoY decrease of 5393.74% (in 2021) over the last 5 years.
  • Over the past 5 years, ReposiTrak's Other Operating Expenses (Quarter) stood at $2.2 million in 2021, then grew by 6.2% to $2.3 million in 2022, then increased by 9.26% to $2.5 million in 2023, then rose by 8.85% to $2.8 million in 2024, then fell by 2.06% to $2.7 million in 2025.
  • Its Other Operating Expenses was $2.7 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.6 million in Q1 2025.